The investment round was led by Stanley Black & Decker’s venture capital arm, with “significant participation” from Samsung Ventures and additional funding from BioAdvance, Hikma Ventures, Hackensack Meridian Health and Civilization Ventures. Pillo Health will use the funds for further development of its medication reminder tool and other at-home digital health solutions.
The medication adherence platform comprises a HIPAA-compliant countertop device that utilizes conversational AI and facial recognition to dispense prescription medicines at the appropriate times. The tool provides information about patients’ adherence directly to their physicians, and can also give patients information about their prescribed health plans via voice or video.
More articles about AI:
Verily’s AI predicts disease biomarkers ‘significantly better’ than existing models
Physician viewpoint: AI will reduce healthcare costs, improve physician wellbeing
NIH’s updated roadmap for AI in radiology focuses on clinical use
